131 related articles for article (PubMed ID: 2996440)
1. [Basic and clinical study of liver cancer using intra-arterial infusion of an emulsion of the oily contrast medium lipiodol with 5-FU].
Tada I; Kobayashi M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1938-9. PubMed ID: 2996440
[TBL] [Abstract][Full Text] [Related]
2. [Arterial infusion of anticancer agent and lipiodol using a totally implanted drug delivery system].
Kishimoto W; Nonami T; Nakao A; Harada A; Kuroe K; Haba T; Takagi H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2531-4. PubMed ID: 2843118
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of concentrated CDDP-lipiodol emulsion for hepatic arterial infusion therapy in patients with nonresectable hepatoma].
Nakashima K; Iwao Y; Suzuki K; Tada I; Kim YI; Kobayashi M; Mori K; Takayama F; Takeyama M; Aikawa H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1731-5. PubMed ID: 2167645
[TBL] [Abstract][Full Text] [Related]
4. [Effect of lipiodol emulsion and local hyperthermia on hepatic tissue blood flow in rabbits with VX-2 liver tumor].
Suzuki K; Tada I; Okada K; Kim YI; Kobayashi M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2491-6. PubMed ID: 2843112
[TBL] [Abstract][Full Text] [Related]
5. [Accumulation of lipiodol in hepatocellular carcinoma after transarterial chemoembolization with 5 FU-lipiodol-emulsion].
Okada K; Tada I; Suzuki K; Kim YI; Kobayashi M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2557-61. PubMed ID: 2843123
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
[TBL] [Abstract][Full Text] [Related]
7. [Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
Ichikawa W; Nihei Z; Sawai S; Yamashita T; Uetake H; Kawachi Y; Hirayama R; Mishima Y; Tamaru H
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1550-2. PubMed ID: 1326920
[TBL] [Abstract][Full Text] [Related]
8. [Microscopic changes in the human liver after intra-arterial infusion of anticancer agents suspended in lipiodol].
Taniguchi H; Yamaguchi T; Kondo S; Shimotsuma M; Sawai K; Takahashi T; Hosokawa Y; Kamachi M; Ashihara T
Gan No Rinsho; 1988 Feb; 34(2):143-9. PubMed ID: 2450212
[TBL] [Abstract][Full Text] [Related]
9. [Studies on drug release from anti-cancer drug suspended Lipiodol].
Isshiki K; Kishimoto W; Nonami T; Kato H; Haba T; Nakao A; Harada A; Takagi H; Kato M; Mizoguchi M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3019-23. PubMed ID: 2551242
[TBL] [Abstract][Full Text] [Related]
10. [Transcatheter arterial infusion of adriamycin-lipiodol suspension to patients with metastatic liver tumor].
Suzuki Y; Sano A; Hatabu H; Imanaka K; Takahashi M; Sadato N; Tamaki T; Fujiwara K; Miki Y; Kawakami K
Gan To Kagaku Ryoho; 1992 Mar; 19(3):323-6. PubMed ID: 1311913
[TBL] [Abstract][Full Text] [Related]
11. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
[TBL] [Abstract][Full Text] [Related]
12. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
Aogi K; Sawamura A; Funakoshi M; Toge T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effects of intraarterial infusion of TNF-lipiodol emulsion on hepatic tumor in rabbit: preliminary report].
Watanabe D; Shinomiya Y; Ueo H; Inoue H; Arinaga S; Abe R; Akiyoshi T
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1653. PubMed ID: 2175840
[No Abstract] [Full Text] [Related]
15. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
16. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol].
Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224
[TBL] [Abstract][Full Text] [Related]
17. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
20. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
